NEW YORK (GenomeWeb News) - Bruker BioSciences said today that it closed its acquisition of molecular spectroscopy company Bruker Optics on July 1.
The $135 million purchase price was paid approximately 59 percent in cash and 41 percent in Bruker BioSciences stock. The company said that it issued around 11.4 million new shares for the stock component of the purchase.
The number of shares was determined by dividing the value of the stock consideration, $55.8 million, by $4.91, the trailing average of Bruker closing prices per share for the period of ten consecutive trading days ending three days prior to the closing date.
Bruker BioSciences announced its plan to acquire Bruker Optics in April.